Mel Hayes

2023

In 2023, Mel Hayes earned a total compensation of $2.2M as Executive Vice President, Patient Affairs at Fulcrum Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$160,300
Option Awards$1,561,354
Salary$471,200
Total$2,192,854

Hayes received $1.6M in option awards, accounting for 71% of the total pay in 2023.

Hayes also received $160.3K in non-equity incentive plan and $471.2K in salary.

Rankings

In 2023, Mel Hayes' compensation ranked 468th out of 2,907 executives tracked by ExecPay. In other words, Hayes earned more than 83.9% of executives.

ClassificationRankingPercentile
All
468
out of 2,907
84th
Division
Manufacturing
270
out of 1,599
83rd
Major group
Chemicals And Allied Products
186
out of 901
79th
Industry group
Drugs
183
out of 864
79th
Industry
Pharmaceutical Preparations
114
out of 622
82nd
Source: SEC filing on April 19, 2024.

Hayes' colleagues

We found five more compensation records of executives who worked with Mel Hayes at Fulcrum Therapeutics in 2023.

2023

Alex Sapir

Fulcrum Therapeutics

Chief Executive Officer

2023

Curtis Oltmans

Fulcrum Therapeutics

Chief Legal Officer

2023

Alan Musso

Fulcrum Therapeutics

Chief Financial Officer

2023

Bryan Stuart

Fulcrum Therapeutics

Chief Executive Officer

2023

Robert Gould

Fulcrum Therapeutics

Chief Executive Officer

News

In-depth

You may also like